Evidence map›Paper›PMID 33038762›Full record

ArticleEBioMedicine2020

Pharmacological validation of targets regulating CD14 during macrophage differentiation.

Gisela Jimenez-Duran, Rosario Luque-Martin, Meghana Patel, Emma Koppe, Sharon Bernard, Catriona Sharp, Natalie Buchan, Ceara Rea, Menno P J de Winther, Nil Turan and 5 more

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. The Spermidine Synthase Gene as a Reporter of Transcription Inhibition inInternational journal of molecular sciences · 2026
    Article
  2. TET1 deficiency amplifies macrophage inflammatory signaling associated with Crohn's disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The combination of hyaluronic acids and collagen boosts human Achilles tendon-derived cell escape from inflammation and matrix remodeling in vitro.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Gisela Jimenez-DuranImmunology Catalyst, Immunology Network, Adaptive Immunity Research Unit, GSK, Stevenage, UK; Institute of Infection and Immunity, Medical School, University Hospital of Wales, Cardiff University, Wales, UK.
Rosario Luque-MartinDepartment of Medical Biochemistry, Experimental Vascular Biology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Meghana PatelImmunology Catalyst, Immunology Network, Adaptive Immunity Research Unit, GSK, Stevenage, UK; Cambridge Academy of Therapeutic Sciences (CATS), University of Cambridge, 17 Mill Lane, Cambridge, CB2 1RX.
Emma KoppeImmunology Catalyst, Immunology Network, Adaptive Immunity Research Unit, GSK, Stevenage, UK.
Sharon BernardImmuno-Epigenetics, Adaptive Immunity Research Unit, GSK, Stevenage, UK.
Catriona SharpImmuno-Epigenetics, Adaptive Immunity Research Unit, GSK, Stevenage, UK.
Natalie BuchanHuman Genetics Computational Biology, Human Genetics, GSK, Stevenage, UK.
Ceara ReaMolecular Design, Data and Computational Sciences, GSK, Stevenage, UK.
Menno P J de WintherDepartment of Medical Biochemistry, Experimental Vascular Biology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Nil TuranImmuno-Epigenetics, Adaptive Immunity Research Unit, GSK, Stevenage, UK.
Davina AngellImmuno-Epigenetics, Adaptive Immunity Research Unit, GSK, Stevenage, UK.
Christine A WellsCentre for Stem Cell Systems, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia.
Rick CousinsImmunology Catalyst, Immunology Network, Adaptive Immunity Research Unit, GSK, Stevenage, UK; Cinnabar Consulting Limited, Bedford, UK.
Palwinder K ManderImmuno-Epigenetics, Adaptive Immunity Research Unit, GSK, Stevenage, UK. Electronic address: palwinder.k.mander@gsk.com.
Seth L MastersImmunology Catalyst, Immunology Network, Adaptive Immunity Research Unit, GSK, Stevenage, UK; Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia; Department of Medical Biology, The University of Melbourne, Parkville, Australia. Electronic address: masters@wehi.edu.au.
Age UK · GBCatalyst · GBAmsterdam University Medical Centers · NLCardiff University · GBUniversity of Amsterdam · NLUniversity of Cambridge · GBUniversity of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The signalling receptor for LPS, CD14, is a key marker of, and facilitator for, pro-inflammatory macrophage function. Pro-inflammatory macrophage differentiation remains a process facilitating a broad array of disease pathologies, and has recently emerged as a potential target against cytokine storm in COVID19. Here, we perform a whole-genome CRISPR screen to identify essential nodes regulating CD14 expression in myeloid cells, using the differentiation of THP-1 cells as a starting point. This strategy uncovers many known pathways required for CD14 expression and regulating macrophage differentiation while additionally providing a list of novel targets either promoting or limiting this process. To speed translation of these results, we have then taken the approach of independently validating hits from the screen using well-curated small molecules. In this manner, we identify pharmacologically tractable hits that can either increase CD14 expression on non-differentiated monocytes or prevent CD14 upregulation during macrophage differentiation. An inhibitor for one of these targets, MAP2K3, translates through to studies on primary human monocytes, where it prevents upregulation of CD14 following M-CSF induced differentiation, and pro-inflammatory cytokine production in response to LPS. Therefore, this screening cascade has rapidly identified pharmacologically tractable nodes regulating a critical disease-relevant process.

Indexed as

BiomarkersCell DifferentiationCells, CulturedCytokinesHumansImmunophenotypingLeukocytes, MononuclearLipopolysaccharide ReceptorsLipopolysaccharidesMacrophagesTHP-1 CellsBiomarkersCD14 protein, humanCytokinesLipopolysaccharide ReceptorsLipopolysaccharides

Identifiers

PMID33038762
PMCPMC7648121
OpenAlexW3092366362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.